OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN

L.B. Menovshchikova; Z.Z. Sottayeva

OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN

L.B. Menovshchikova, Z.Z. Sottayeva

Abstract

This article describes an experience of treatment of children (n=92) with miction disorders – syndrome of hyperactive urinary bladder (HUB) with oxybutynin (Driptane). Treatment resulted in decrease of median grade of disorder of urination from 12.5 marks initially to 5.2 marks after 4 weeks of treatment. This effect remained during 3 following months. Besides, the frequency of urinations was lessened in 23%, urgent feeling of urination – in 46%, urgent incontinence was stopped completely. Symptoms of enuresis were more resistant to treatment, and they were stopped completely in 6 children. Side effects, concerned with therapy, were registered in 3 (3%) children. Thus, oxybutynin in effective and safe medication for treatment of children with urinary disorders – HUB syndrome.
Key words: children, syndrome of hyperactive urinary bladder, treatment, oxybutynin.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(1):104-107)

About the Authors

L.B. Menovshchikova

Russian State Medical University, Moscow
Russian Federation

Z.Z. Sottayeva

Russian State Medical University, Moscow
Russian Federation

References

1. Вишневский Е.Л., Лоран О.Б., Вишневский А.Л. Клиническая оценка расстройств мочеиспускания. М. 2001.

2. Вишневский Е.Л., Казанская И.В., Игнатьев Р.О., Гусева Н.Б. Эффективность лечения гиперактивного мочевого пузыря у детей дриптаном. Врачебное сословие. 2005; 4–5: 32–35.

3. Гусарова Т.Н., Зоркин С.Н. Оценка эффективности применения оксибутинина (Дриптана) у детей с гиперактивностью мочевого пузыря. Педиатрия. 2006; 5: 67–71.

4. Казанская И.В., Вишневский Е.Л., Игнатьев Р.О. и др. Роль М–холинолитиков в реабилитации детей с расстройствами мочеиспускания при ГАМП. Вопросы современной педиатрии. 2006; 5 (3): 65–68.

5. Кольбе О.Б., Моисеев А.Б., Сазонов А.Н. и др. Оценка эффективности применения препарата оксибутинин у детей с гиперактивным мочевым пузырем. Русский медицинский журнал. 2006; 14 (12): 865–897.

6. Пугачев А.Г., Ромих ВВ., Алферов С.Н. Клинические особенности функциональных нарушений мочеиспускания в детском возрасте. Лечащий врач. 2004; 9: 32–35.

7. Abrams P., Cardozo L., Fall M. et al. The Standardization of Terminology of lower urinary tract function; Report from the Standardisation Sub-committee of the international Continence Society. Neurology and Urodynamics. 2002; 21: 167–178.

8. Bauer S., Koff S.A., Jayanthi V.R. Voiding dysfunction children and non-neurogenic. Philadelphia Penna: WB Saunders Co. 2002. 2231–2283.

9. Vega P., Pascual L.A. High-pressure bladder: an underlying tactor mediating renal damage in the absence of reflux? BJU. 2001; 87 (6): 581–584.

10. Castro J., Soares E., Casimiro A., Nogueria G. Bladder malfunction, urinary infection and vesicoureteral reflux in children. Acta Med. Port. 1998; 11 (7): 635–642.

Review

For citations:

Menovshchikova L., Sottayeva Z. OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN. Current Pediatrics. 2009;8(1):104-107.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Current Pediatrics

OXYBUTYNIN IN TREATMENT OF HYPERACTIVE URINARY BLADDER IN CHILDREN

Abstract

About the Authors

References

Review

For citations:

Cookies policy